These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32485633)

  • 1. Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis.
    Moraes AG; Neri SGR; Motl RW; Tauil CB; Glehn FV; Corrêa ÉC; de David AC
    Mult Scler Relat Disord; 2020 Aug; 43():102203. PubMed ID: 32485633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hippotherapy on postural balance, functional mobility, self-perceived fatigue, and quality of life in people with relapsing-remitting multiple sclerosis: Secondary results of an exploratory clinical trial.
    Moraes AG; Neri SGR; Motl RW; Tauil CB; von Glehn F; Corrêa ÉC; de David AC
    Mult Scler Relat Disord; 2021 Jul; 52():102948. PubMed ID: 33940496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
    Lindroth JL; Sullivan JL; Silkwood-Sherer D
    Physiother Theory Pract; 2015; 31(8):575-81. PubMed ID: 26467902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait pattern changes after six-minute walk test in persons with multiple sclerosis.
    Escudero-Uribe S; Hochsprung A; Izquierdo-Ayuso G
    Physiother Res Int; 2019 Jan; 24(1):e1741. PubMed ID: 30192036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
    Zörner B; Filli L; Reuter K; Kapitza S; Lörincz L; Sutter T; Weller D; Farkas M; Easthope CS; Czaplinski A; Weller M; Linnebank M
    Mult Scler; 2016 Oct; 22(11):1463-1475. PubMed ID: 26762672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?
    Novotna K; Rusz J; Kubala Havrdova E; Lizrova Preiningerova J
    J Neural Transm (Vienna); 2019 Jun; 126(6):731-737. PubMed ID: 31098724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a hippotherapy session on spatiotemporal parameters of gait in children with cerebral palsy - pilot study.
    Manikowska F; Jóźwiak M; Idzior M; Chen PJ; Tarnowski D
    Ortop Traumatol Rehabil; 2013 Jun; 15(3):253-7. PubMed ID: 23898002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do textured insoles affect postural control and spatiotemporal parameters of gait and plantar sensation in people with multiple sclerosis?
    Kalron A; Pasitselsky D; Greenberg-Abrahami M; Achiron A
    PM R; 2015 Jan; 7(1):17-25. PubMed ID: 25153447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Gait Characteristics During and Immediately After the 6-Minute Walk Test in Persons With Multiple Sclerosis: A Systematic Review.
    Abasıyanık Z; Kahraman T; Veldkamp R; Ertekin Ö; Kalron A; Feys P
    Phys Ther; 2022 Jul; 102(7):. PubMed ID: 35358308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis.
    Zörner B; Hostettler P; Meyer C; Killeen T; Gut P; Linnebank M; Weller M; Straumann D; Filli L
    Mult Scler Relat Disord; 2022 Jul; 63():103802. PubMed ID: 35487034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal gait changes in people with multiple sclerosis with different disease progression subtypes.
    Sato SD; Hiroi Y; Zoppo D; Buonaccorsi J; Miehm JD; van Emmerik REA
    Clin Biomech (Bristol, Avon); 2022 Dec; 100():105818. PubMed ID: 36435079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trunk and pelvis movement compensation in people with multiple sclerosis: Relationships to muscle function and gait performance outcomes.
    Mañago MM; Kline PW; Alvarez E; Christiansen CL
    Gait Posture; 2020 May; 78():48-53. PubMed ID: 32200163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis.
    Aristotelous P; Stefanakis M; Pantzaris M; Pattichis CS; Calder PC; Patrikios IS; Sakkas GK; Giannaki CD
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
    Mañago MM; Callesen J; Dalgas U; Kittelson J; Schenkman M
    Mult Scler Relat Disord; 2020 Jul; 42():102052. PubMed ID: 32240963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of mechanical hippotherapy and Cawthorne-Cooksey exercises in patients with multiple sclerosis: Randomized trial.
    Kabuk A; Şevgin Ö
    Mult Scler Relat Disord; 2024 Jul; 87():105697. PubMed ID: 38833975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
    Voloshyna N; Havrdová E; Hutchinson M; Nehrych T; You X; Belachew S; Hotermans C; Paes D
    Eur J Neurol; 2015 Mar; 22(3):570-7. PubMed ID: 25511792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.